Exton, PA, United States of America

Kim Hung Lo

This inventor holds 4 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim Hung Lo. Retrieved from https://idiyas.com/inventor/kim-hung-lo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kim Hung Lo: Innovator in Anti-TNF Antibody Treatments

Introduction

Kim Hung Lo is a notable inventor based in Exton, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for autoimmune diseases. With a total of 4 patents to his name, his work has the potential to impact many lives.

Latest Patents

Among his latest patents are innovative compositions and methods utilizing anti-TNF antibodies. One of his notable inventions focuses on the treatment of active Ankylosing Spondylitis. This invention relates to compositions and methods that utilize anti-TNF antibodies with a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37. This formulation aims to provide a safe and effective treatment for individuals suffering from active Ankylosing Spondylitis (AS). Another patent addresses the treatment of active Psoriatic Arthritis (PsA) using similar anti-TNF antibodies.

Career Highlights

Kim Hung Lo is currently associated with Janssen Biotech, Inc., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to developing effective therapies for chronic inflammatory conditions.

Collaborations

He collaborates with esteemed colleagues, including Diane Deborah Harrison and Elizabeth C Hsia, to advance research and development in his field.

Conclusion

Kim Hung Lo's contributions to the development of anti-TNF antibody treatments highlight his role as a significant inventor in biotechnology. His innovative work continues to pave the way for new therapeutic options for patients with autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…